Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients
 with Recurrent Major Depressive Disorder
Inclusion Criteria:

 -  Diagnosed with recurrent major depressive disorder

 Exclusion Criteria:

 -  Patients with treatment resistance for depression

 -  History of alcohol abuse/dependence, substance abuse/dependence within 6 months

 -  Has clinically significant unstable medical condition

 -  Has significant risk of suicide